Page last updated: 2024-09-05

sorafenib and voriconazole

sorafenib has been researched along with voriconazole in 3 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(voriconazole)
Trials
(voriconazole)
Recent Studies (post-2010) (voriconazole)
6,5207305,2514,3902192,678

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)voriconazole (IC50)
Cytochrome P450 2C9 Homo sapiens (human)8.4
Cytochrome P450 2C19Homo sapiens (human)8.7
Cholesterol 24-hydroxylaseHomo sapiens (human)0.0345

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Baker, SD; Chaudhry, AS; Finkelstein, D; Gibson, A; Inaba, H; Li, L; Roberts, JL; Rubnitz, JE; Schuetz, EG; Zimmerman, EI1
Freyer, CW; Mangan, JK1

Reviews

1 review(s) available for sorafenib and voriconazole

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for sorafenib and voriconazole

ArticleYear
Ontogeny and sorafenib metabolism.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Oct-15, Volume: 18, Issue:20

    Topics: Adolescent; Age Factors; Azoles; Child; Child, Preschool; Cytochrome P-450 CYP3A; Female; Humans; Infant; Infant, Newborn; Liver; Male; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyrimidines; Sex Factors; Sorafenib; Triazoles; Voriconazole; Young Adult

2012

Other Studies

1 other study(ies) available for sorafenib and voriconazole

ArticleYear
Dose-related periorbital edema following sorafenib in a patient with acute myeloid leukemia.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2019, Volume: 25, Issue:8

    Topics: Aged; Antineoplastic Agents; Edema; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Male; Mutation; Sorafenib; Voriconazole

2019